Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $387.08 million. The enterprise value is $12.40 million.

Market Cap	387.08M
Enterprise Value	12.40M

Important Dates

The last earnings date was Thursday, March 6, 2025, after market close.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 35.00 million shares outstanding.

Current Share Class	35.00M
Shares Outstanding	35.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	68.38%
Float	22.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.09
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.89, with a Debt / Equity ratio of 0.00.

Current Ratio	28.89
Quick Ratio	28.80
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-60.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-25.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.80%
50-Day Moving Average	13.25
200-Day Moving Average	27.20
Relative Strength Index (RSI)	46.10
Average Volume (20 Days)	224,085

Short Selling Information

The latest short interest is 1.76 million, so 5.03% of the outstanding shares have been sold short.

Short Interest	1.76M
Short Previous Month	1.70M
Short % of Shares Out	5.03%
Short % of Float	7.98%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-96.13M
Pretax Income	n/a
Net Income	-91.34M
EBITDA	-96.10M
EBIT	-96.13M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $375.65 million in cash and $968,000 in debt, giving a net cash position of $374.68 million or $10.71 per share.

Cash & Cash Equivalents	375.65M
Total Debt	968,000
Net Cash	374.68M
Net Cash Per Share	$10.71
Equity (Book Value)	382.22M
Book Value Per Share	118.60
Working Capital	363.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-63.09M
Capital Expenditures	-206,182
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-23.60%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for ORKA is $39.67, which is 258.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.67
Price Target Difference	258.68%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	0.083333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1